Condensed Consolidated Statements of Stockholders' Equity (unaudited) - USD ($)	Total	Common Stock	Additional Paid In Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2020		4,258,105
Beginning balance at Dec. 31, 2020	$ 35,492,242	$ 4,259	$ 100,203,979	$ (64,689,065)	$ (26,931)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		65,962
Exercise of stock options	579,619	$ 66	579,553
Restricted stock issued (in shares)		6,527
Restricted stock issued	0	$ 6	(6)
Debt issuance cost associated with debt conversion	0
Stock based compensation	745,620		745,620
Net loss	(2,844,230)			(2,844,230)
Other comprehensive income - foreign currency translation adjustment	12,501				12,501
Ending balance (in shares) at Mar. 31, 2021		4,330,594
Ending balance at Mar. 31, 2021	33,985,752	$ 4,331	101,529,146	(67,533,295)	(14,430)
Beginning balance (in shares) at Dec. 31, 2021		4,909,846
Beginning balance at Dec. 31, 2021	46,839,808	$ 4,910	108,569,988	(61,680,275)	(54,815)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Return of profit	5,824		5,824
Exercise of stock options (in shares)		7,097
Exercise of stock options	91,634	$ 7	91,627
Restricted stock issued (in shares)		31,746
Restricted stock issued	0	$ 32	(32)
Stock issued from converted debt( in shares )		130,916
Stock issued from converted debt	2,571,200	$ 131	2,571,069
Debt issuance cost associated with debt conversion	(109,399)		(109,399)
Stock based compensation	2,079,159		2,079,159
Net loss	(12,187,830)			(12,187,830)
Other comprehensive income - foreign currency translation adjustment	(27,150)				(27,150)
Ending balance (in shares) at Mar. 31, 2022		5,079,605
Ending balance at Mar. 31, 2022	$ 39,263,246	$ 5,080	$ 113,208,236	$ (73,868,105)	$ (81,965)